Medy-Tox Inc. (KOSDAQ:086900)
South Korea · Delayed Price · Currency is KRW 108,600
+1,100 (1.02%)
Apr 29, 2026, 3:30 PM KST
Medy-Tox Cash Flow Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 16,594 | 16,955 | 9,755 | 37,010 | 94,154 |
Depreciation & Amortization | 20,067 | 19,959 | 15,376 | 15,101 | 18,256 |
Loss (Gain) From Sale of Assets | 4,312 | -323.58 | 671.97 | 230.42 | -131.48 |
Asset Writedown & Restructuring Costs | - | 8,624 | - | - | 12,932 |
Loss (Gain) From Sale of Investments | 4,380 | -125.73 | 593.36 | 3,044 | -2,666 |
Loss (Gain) on Equity Investments | 1,930 | -5,877 | -1,363 | -5,129 | 1,456 |
Stock-Based Compensation | -97.17 | -552.97 | 1,832 | 1,807 | 3,902 |
Provision & Write-off of Bad Debts | 2,599 | 4,885 | 546.64 | 4,869 | 1,162 |
Other Operating Activities | -11,183 | 1,258 | 2,174 | -1,232 | -79,469 |
Change in Accounts Receivable | 14,615 | 4,319 | -35,633 | -22,969 | 4,440 |
Change in Inventory | 20,631 | -3,449 | -8,905 | -19,462 | 1,405 |
Change in Accounts Payable | -13,183 | -3,373 | 19,508 | 840.32 | 807.57 |
Change in Unearned Revenue | 62.32 | 177.95 | - | - | - |
Change in Other Net Operating Assets | 682.34 | -5,921 | 8,966 | 12,089 | -36,282 |
Operating Cash Flow | 61,410 | 36,556 | 13,522 | 26,199 | 19,966 |
Operating Cash Flow Growth | 67.99% | 170.35% | -48.39% | 31.22% | -28.51% |
Capital Expenditures | -15,661 | -8,726 | -7,660 | -9,895 | -17,514 |
Sale of Property, Plant & Equipment | 683.02 | 267.51 | 25.73 | 23.05 | 1,171 |
Cash Acquisitions | -265.9 | -4,920 | - | -911.23 | - |
Sale (Purchase) of Intangibles | -18,549 | -9,714 | -29,809 | -15,205 | -3,830 |
Investment in Securities | 12,245 | 21,111 | 47,388 | -10,066 | -11,803 |
Other Investing Activities | 1,655 | 1,074 | 2,338 | 465.62 | 4,004 |
Investing Cash Flow | -20,628 | -646.92 | 13,255 | -36,124 | -27,777 |
Short-Term Debt Issued | - | 20,000 | 41,230 | 37,303 | 19,750 |
Total Debt Issued | - | 20,000 | 41,230 | 37,303 | 19,750 |
Short-Term Debt Repaid | -4,686 | -20,561 | -43,905 | -38,000 | -38,590 |
Long-Term Debt Repaid | -897.2 | -759.22 | -5,624 | -12,634 | -918.71 |
Total Debt Repaid | -5,584 | -21,321 | -49,529 | -50,634 | -39,508 |
Net Debt Issued (Repaid) | -5,584 | -1,321 | -8,299 | -13,331 | -19,758 |
Issuance of Common Stock | 49.72 | 141.2 | 9,943 | - | - |
Repurchase of Common Stock | -13,150 | -10,148 | -2,972 | -16,935 | -8,125 |
Dividends Paid | -8,919 | -8,424 | -8,422 | -8,045 | - |
Other Financing Activities | -10,030 | -4,296 | -3,794 | -2,077 | -2,313 |
Financing Cash Flow | -37,634 | -24,048 | -13,544 | -40,388 | 34,804 |
Foreign Exchange Rate Adjustments | -421.86 | 1,061 | -674.63 | -777.04 | 791.78 |
Net Cash Flow | 2,726 | 12,922 | 12,558 | -51,089 | 27,784 |
Free Cash Flow | 45,749 | 27,830 | 5,862 | 16,304 | 2,452 |
Free Cash Flow Growth | 64.39% | 374.76% | -64.05% | 564.95% | - |
Free Cash Flow Margin | 18.50% | 12.17% | 2.65% | 8.36% | 1.33% |
Free Cash Flow Per Share | 6944.77 | 4138.95 | 875.31 | 2483.66 | 382.01 |
Cash Interest Paid | 1,411 | 4,330 | 3,804 | 2,413 | 3,632 |
Cash Income Tax Paid | 6,820 | 7,456 | 13,486 | 18,876 | 17,991 |
Levered Free Cash Flow | 12,485 | 25,136 | -25,434 | -7,850 | 14,556 |
Unlevered Free Cash Flow | 12,890 | 26,215 | -23,976 | -6,404 | 17,544 |
Change in Working Capital | 22,808 | -8,245 | -16,064 | -29,501 | -29,630 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.